250 related articles for article (PubMed ID: 16860036)
1. Predictors for the development of elevated anti-heparin/platelet factor 4 antibody titers in patients undergoing cardiac catheterization.
Yeh RW; Everett BM; Foo SY; Dorer DJ; Laposata M; Van Cott EM; Jang IK
Am J Cardiol; 2006 Aug; 98(3):419-21. PubMed ID: 16860036
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization.
Foo SY; Everett BM; Yeh RW; Criss D; Laposata M; Van Cott EM; Jang IK
Am Heart J; 2006 Aug; 152(2):290.e1-7. PubMed ID: 16875910
[TBL] [Abstract][Full Text] [Related]
3. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up.
Mattioli AV; Bonetti L; Zennaro M; Ambrosio G; Mattioli G
Am Heart J; 2009 Mar; 157(3):589-95. PubMed ID: 19249435
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery.
Everett BM; Yeh R; Foo SY; Criss D; Van Cott EM; Laposata M; Avery EG; Hoffman WD; Walker J; Torchiana D; Jang IK
Ann Thorac Surg; 2007 Feb; 83(2):592-7. PubMed ID: 17257993
[TBL] [Abstract][Full Text] [Related]
5. Thrombotic events in patients with antiplatelet factor 4/heparin antibodies.
Mattioli AV; Bonetti L; Carletti U; Ambrosio G; Mattioli G
Heart; 2009 Aug; 95(16):1350-4. PubMed ID: 19482851
[TBL] [Abstract][Full Text] [Related]
6. Studies of the anti-platelet factor 4/heparin immune response: adapting the enzyme-linked immunosorbent spot assay for detection of memory B cells against complex antigens.
Selleng K; Schütt A; Selleng S; Warkentin TE; Greinacher A
Transfusion; 2010 Jan; 50(1):32-9. PubMed ID: 19709391
[TBL] [Abstract][Full Text] [Related]
7. The incidence and implications of anti-heparin-platelet factor 4 antibody formation in a pediatric cardiac surgical population.
Mullen MP; Wessel DL; Thomas KC; Gauvreau K; Neufeld EJ; McGowan FX; Dinardo JA
Anesth Analg; 2008 Aug; 107(2):371-8. PubMed ID: 18633010
[TBL] [Abstract][Full Text] [Related]
8. Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery.
Selleng S; Malowsky B; Itterman T; Bagemühl J; Wessel A; Wollert HG; Warkentin TE; Greinacher A
Am Heart J; 2010 Aug; 160(2):362-9. PubMed ID: 20691844
[TBL] [Abstract][Full Text] [Related]
9. Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies.
Pouplard C; May MA; Regina S; Marchand M; Fusciardi J; Gruel Y
Br J Haematol; 2005 Mar; 128(6):837-41. PubMed ID: 15755289
[TBL] [Abstract][Full Text] [Related]
10. Incidence of antiheparin-platelet factor 4 antibodies and heparin-induced thrombocytopenia in Turkish patients undergoing cardiac surgery.
Demir M; Duran E; Yigitbasi O; Vural O; Kurum T; Yuksel M; Turgut B; Walenga JM; Fareed J
Clin Appl Thromb Hemost; 2007 Jul; 13(3):279-84. PubMed ID: 17636189
[TBL] [Abstract][Full Text] [Related]
11. Urgent cardiac surgery in a patient with a remote history of heparin-induced thrombocytopenia: use of the anti-PF4/heparin ELISA confirmatory test.
Dellaria SM; Greilich PE; Sarode R
Anesth Analg; 2008 Aug; 107(2):379-81. PubMed ID: 18633011
[TBL] [Abstract][Full Text] [Related]
12. Preoperative anti-PF4/heparin antibody level predicts adverse outcome after cardiac surgery.
Bennett-Guerrero E; Slaughter TF; White WD; Welsby IJ; Greenberg CS; El-Moalem H; Ortel TL
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1567-72. PubMed ID: 16308000
[TBL] [Abstract][Full Text] [Related]
13. Profiling of heparin-induced thrombocytopenia antibody levels in patients with and without diabetes.
Diaz J; Prechel M; Emanuele M; Emanuele N; Walenga JM
Clin Appl Thromb Hemost; 2010 Apr; 16(2):121-5. PubMed ID: 20299390
[TBL] [Abstract][Full Text] [Related]
14. Heparin-induced thrombocytopenia in patients treated with unfractionated heparin: prevalence of thrombosis in a 1 year follow-up.
Mattioli AV; Bonetti L; Sternieri S; Mattioli G
Ital Heart J; 2000 Jan; 1(1):39-42. PubMed ID: 10868921
[TBL] [Abstract][Full Text] [Related]
15. Positive heparin-platelet factor 4 antibody complex and cardiac surgical outcomes.
Kress DC; Aronson S; McDonald ML; Malik MI; Divgi AB; Tector AJ; Downey FX; Anderson AJ; Stone M; Clancy C
Ann Thorac Surg; 2007 May; 83(5):1737-43. PubMed ID: 17462391
[TBL] [Abstract][Full Text] [Related]
16. Thrombosis in suspected heparin-induced thrombocytopenia occurs more often with high antibody levels.
Baroletti S; Hurwitz S; Conti NA; Fanikos J; Piazza G; Goldhaber SZ
Am J Med; 2012 Jan; 125(1):44-9. PubMed ID: 22075045
[TBL] [Abstract][Full Text] [Related]
17. Incidence of heparin-PF4 complex antibody formation and heparin-induced thrombocytopenia in acute coronary syndrome.
Matsuo T; Tomaru T; Kario K; Hirokawa T;
Thromb Res; 2005; 115(6):475-81. PubMed ID: 15792678
[TBL] [Abstract][Full Text] [Related]
18. Heparin-induced thrombocytopenia in patients receiving mechanical circulatory support.
Schenk S; El-Banayosy A; Prohaska W; Arusoglu L; Morshuis M; Koester-Eiserfunke W; Kizner L; Murray E; Eichler P; Koerfer R; Greinacher A
J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1373-81.e4. PubMed ID: 16733172
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.
Carrier M; Knoll GA; Kovacs MJ; Moore JC; Fergusson D; Rodger MA
Thromb Res; 2007; 120(2):215-20. PubMed ID: 17098277
[TBL] [Abstract][Full Text] [Related]
20. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]